/PRNewswire/ Invitae (NYSE: NVTA), a leading medical genetics company, today announced that members of its management team will participate in the following.
Invitae Corporation (NYSE:NYSE:NVTA) Q1 2022 Results Conference Call May 03, 2022 04:30 PM ET Company Participants Jack Finks - IR Sean George - CEO Roxi Wen - CFO Conference Call.
/PRNewswire/ Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its first quarter 2022 financial.